The Office of Personnel Management’s 2018: Federal Workforce Priorities Report reiterates what other studies have shown: Workers spend too much time sitting and not enough time doing some sort of physical activity. The OPM wants government agencies to focus more on giving workers opportunities to be more active at work.
People with less money have a greater chance of getting dementia. Researchers looked at 6,220 English patients ages 65 and older, in 2002–2003 and again in 2014–2015. In those 12 years, those in the lowest wealth quintile had 1.68 times more likelihood of getting dementia than those in the highest quintile.
For anyone who’s ever felt that five minutes after you’ve been on vacation it seems as though you’d never gone, you’re not alone.
A state lawmaker calls insulin prices ‘outrageous.’ PhRMA and BIO are fighting the law in court on grounds that it interferes with their patent rights.
With accumulators, the value of any copay assistance cards or coupons does not count toward out-of-pocket medicine costs that are applied toward deductibles. It’s a cost-shifting tool that’s facing pushback from patients, providers, and others saying that accumulators will hurt public health.
Next month, the Sanofi and Regeneron product is expected to become the fourth monoclonal antibody approved as a treatment for severe asthma.
The “waste-free formulary” under development by the Pacific Business Group on Health sounds promising, but ultimately may not deliver the impact to self-insured employers its creators are promising. The approach glosses over a critical question: What constitutes “high-value”? The definition of value plays a central role in determining the care that patients ultimately receive.
Instead of relying on price comparison tools that insurers offer, patients instead will go where their doctors tell them to go to get MRIs, and in the process drive by an average of six other places where the procedure could have been done more cheaply.
Patient-reported outcomes measures (PROMs) use a patient’s response to questions to measure health status. If they’re going to catch on payers will need to incentivize use. So far, that’s not happening. But clinicians who use PROMs for clinical decision making might be providing a valuable service.
The United States spends more—close to double—on health care per capita than other rich countries. By many measures, we’re not getting a good return on those trillions of dollars.